세계의 펩티드 화장품용 API 시장 : 공급원, 용도, 최종사용자 산업, 지역별(-2035년)

Global Peptide Cosmetic API Research Report by Source (Plant-Derived Peptides, Animal-Derived Peptides, Bioengineered Peptides, Chemically Synthesized), by Application (Anti-Aging & Wrinkle Reduction, Skin Repair & Regeneration, Moisturizing & Hydration, Whitening & Brightening, Hair Care, Anti-Inflammatory & Soothing), by End-Use Industry (Skincare, Haircare, Injectable Cosmetics, Others), by Region (North America, Europe, APAC, South America, MEA) Market Forecast till 2035

Industry Overview

The global peptide cosmetic API market is expected to achieve from its 2024 estimate of USD 921.3 million to USD 2,968.4 million by 2035 at a compound annual growth rate (CAGR) of 11.2%.

Global peptide cosmetic API market is witnessing robust growth, largely fueled by increasing consumer demand for natural and organic beauty solutions. As people become more conscious of skin safety and sustainability, they are turning to peptide-based products that align with clean beauty standards. Rapid technological progress in peptide synthesis has enabled the creation of more stable and effective cosmetic formulations. Moreover, the rising inclination toward personalized skincare regimens has boosted the use of peptides, which can be customized for targeted skin concerns. Expanding dermatological research continues to validate the efficacy of peptides in skincare, further promoting their market adoption.

Nevertheless, the market does encounter several barriers. These include the high cost of synthesis and formulation, challenges in product stability and delivery mechanisms, and complex regulatory processes that can delay product approvals. Competition from alternative active ingredients also poses limitations.

Despite these challenges, growth prospects remain strong, especially in areas like bioengineered peptides, AI-driven skincare, male-focused anti-aging products, multi-step skincare routines, and peptide research innovations.

Industry Segmentations

Based on the application category, the global market is included anti-aging & wrinkle reduction, skin repair & regeneration, moisturizing & hydration, whitening & brightening, hair care, anti-inflammatory & soothing.

Chemically synthesized, plant-derived, animal-derived, and bioengineered peptides are all included in the global peptide cosmetic API market, which is divided by source type.

In terms of end-use variation, the global market is segmented into Skincare, haircare, injectable cosmetics, and others.

Regional Analysis

The global peptide cosmetic API market sees North America leading, thanks to widespread awareness, established skincare brands, and strong interest in functional, anti-aging solutions. Advanced research infrastructure and preference for premium, science-led products are key growth enablers.

Europe is a significant player as well, shaped by clean beauty demand, robust ingredient regulations, and a thriving anti-aging sector in Germany, France, and the UK.

Asia-Pacific is experiencing rapid growth, influenced by K-beauty and J-beauty, surging urbanization, and a young population inclined toward multifunctional skincare in China, Japan, and South Korea.

Latin America is gaining traction, primarily due to Brazil's expanding market for natural and anti-aging cosmetics.

Meanwhile, growth in the Middle East & Africa remains moderate but promising, supported by increasing disposable income and urban expansion.

Key Players

Key competitors of global peptide cosmetic API research report are Chemisches Laboratorium Dr. Kurt Richter GmbH, DSM-Firmenich, Provital Group, Bachem, Lipotrue Science, Croda, Caregen, BASF SE, Evonik Industries AG, Givaudan Active Beauty, Ashland Global Holdings, Symrise AG, Spec-Chem Industry Inc, Ambiopharm, Lipotec, USV Private Limited, Active Peptide Company, Seiwa Kasei Co. Ltd., RS Synthesis, BCN Peptides.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 DATA MINING PROCESS
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 SECONDARY RESEARCH DATA FLOW:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
• 3.6 APPROACHES FOR MARKET END USER ESTIMATION:
  • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.6.2 DATA FORECASTING
  • 3.6.3 DATA FORECASTING TECHNIQUE
• 3.7 DATA MODELING
  • 3.7.1 MICROECONOMIC FACTOR ANALYSIS:
  • 3.7.2 DATA MODELING:
• 3.8 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 INCREASING DEMAND FOR NATURAL AND ORGANIC COSMETICS
  • 4.2.2 TECHNOLOGICAL ADVANCEMENTS IN PEPTIDE SYNTHESIS
  • 4.2.3 GROWING PREFERENCE FOR PERSONALIZED SKINCARE SOLUTIONS
  • 4.2.4 EXPANDING RESEARCH ON PEPTIDE BENEFITS IN DERMATOLOGY
• 4.3 RESTRAINTS
  • 4.3.1 HIGH COST OF PEPTIDE SYNTHESIS AND FORMULATION
  • 4.3.2 STABILITY AND DELIVERY CHALLENGES
  • 4.3.3 REGULATORY COMPLEXITIES AND APPROVAL DELAYS
  • 4.3.4 COMPETITION FROM ALTERNATIVE ACTIVE INGREDIENTS
• 4.4 OPPORTUNITY
  • 4.4.1 BIOENGINEERED PEPTIDES IN CLEAN BEAUTY
  • 4.4.2 AI-DRIVEN PERSONALIZED SKINCARE
  • 4.4.3 PEPTIDES IN MULTI-STEP SKINCARE REGIMENS
  • 4.4.4 MEN'S GROOMING AND ANTI-AGING SOLUTIONS
  • 4.4.5 INNOVATIONS IN PEPTIDE RESEARCH
• 4.5 IMPACT ANALYSIS OF COVID - 19
  • 4.5.1 IMPACT 0N OVERALL HEALTHCARE.
  • 4.5.2 ECONOMIC IMPACT.
  • 4.5.3 IMPACT ON GLOBAL PEPTIDE COSMETIC API MARKET MARKET.
  • 4.5.4 IMPACT ON SUPPLY CHAIN OF PEPTIDE COSMETIC API MARKET
  • 4.5.5 PRICE VARIATION OF KEY RAW MATERIALS.
  • 4.5.6 PRODUCTION SHUTDOWN.
  • 4.5.7 CASH FLOW CONSTRAINTS.
  • 4.5.8 IMPACT ON IMPORT/EXPORT.
  • 4.5.9 IMPACT ON MARKET DEMAND OF PEPTIDE COSMETIC API MARKET.
  • 4.5.10 IMPACT DUE TO RESTRICTIONS/LOCKDOWN.
  • 4.5.11 CONSUMER SENTIMENTS.
  • 4.5.12 IMPACT ON PRICING OF PEPTIDE COSMETIC API MARKET.

5 MARKET FACTOR ANALYSIS

• 5.1 SUPPLY CHAIN ANALYSIS
  • 5.1.1 RAW MATERIAL PROCUREMENT
  • 5.1.2 MANUFACTURING & SYNTHESIS
  • 5.1.3 PACKAGING AND STORAGE
  • 5.1.4 DISTRIBUTION & LOGISTICS
  • 5.1.5 END-USERS & CONSUMER DELIVERY
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 BARGAINING POWER OF SUPPLIERS
  • 5.2.2 BARGAINING POWER OF BUYERS
  • 5.2.3 THREAT OF NEW ENTRANTS
  • 5.2.4 THREAT OF SUBSTITUTES
  • 5.2.5 INTENSITY OF RIVALRY

6 PEPTIDE COSMETIC API MARKET, BY APPLICATION

• 6.1 INTRODUCTION
• 6.2 ANTI-AGING & WRINKLE REDUCTION
• 6.3 SKIN REPAIR & REGENERATION
• 6.4 MOISTURIZING & HYDRATION
• 6.5 WHITENING & BRIGHTENING
• 6.6 HAIR CARE
• 6.7 ANTI-INFLAMMATORY & SOOTHING

7 PEPTIDE COSMETIC API MARKET, BY SOURCE

• 7.1 INTRODUCTION
• 7.2 PLANT-DERIVED PEPTIDES
• 7.3 ANIMAL-DERIVED PEPTIDES
• 7.4 BIOENGINEERED PEPTIDES
• 7.5 CHEMICALLY SYNTHESIZED

8 PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY

• 8.1 INTRODUCTION
• 8.2 SKINCARE
• 8.3 HAIRCARE
• 8.4 INJECTABLE COSMETICS
• 8.5 OTHERS

9 PEPTIDE COSMETIC API MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 NORTH AMERICA
  • 9.2.1 US
  • 9.2.2 CANADA
• 9.3 EUROPE
  • 9.3.1 GERMANY
  • 9.3.2 UK
  • 9.3.3 FRANCE
  • 9.3.4 RUSSIA
  • 9.3.5 ITALY
  • 9.3.6 SPAIN
  • 9.3.7 REST OF EUROPE
• 9.4 APAC
  • 9.4.1 CHINA
  • 9.4.2 INDIA
  • 9.4.3 JAPAN
  • 9.4.4 SOUTH KOREA
  • 9.4.5 MALAYSIA
  • 9.4.6 THAILAND
  • 9.4.7 INDONESIA
  • 9.4.8 REST OF APAC
• 9.5 SOUTH AMERICA
  • 9.5.1 BRAZIL
  • 9.5.2 MEXICO
  • 9.5.3 ARGENTINA
  • 9.5.4 REST OF SOUTH AMERICA
• 9.6 MEA
  • 9.6.1 GCC COUNTRIES
  • 9.6.2 SOUTH AFRICA
  • 9.6.3 REST OF MEA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 MARKET SHARE ANALYSIS, 2023
• 10.3 COMPETITOR DASHBOARD

11 COMPANY PROFILES

• 11.1 DSM-FIRMENICH
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 TYPES OFFERED
  • 11.1.4 PATENT DETAILS
  • 11.1.5 PRODUCTION CAPACITY
  • 11.1.6 SALES VOLUME
  • 11.1.7 PRICING ANALYSIS
  • 11.1.8 SWOT ANALYSIS
  • 11.1.9 KEY STRATEGY
• 11.2 BACHEM
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 TYPES OFFERED
  • 11.2.4 PATENT DETAILS
  • 11.2.5 PRODUCTION CAPACITY
  • 11.2.6 SALES VOLUME
  • 11.2.7 PRICING ANALYSIS
  • 11.2.8 SWOT ANALYSIS
  • 11.2.9 KEY STRATEGY
• 11.3 LIPOTRUE SCIENCE
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 TYPES OFFERED
  • 11.3.3 PATENT DETAILS
  • 11.3.4 PRODUCTION CAPACITY
  • 11.3.5 SALES VOLUME
  • 11.3.6 PRICING ANALYSIS
  • 11.3.7 SWOT ANALYSIS
  • 11.3.8 KEY STRATEGY
• 11.4 CRODA
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 TYPES OFFERED
  • 11.4.4 PATENT DETAILS
  • 11.4.5 PRODUCTION CAPACITY
  • 11.4.6 SALES VOLUME
  • 11.4.7 PRICING ANALYSIS
  • 11.4.8 SWOT ANALYSIS
  • 11.4.9 KEY STRATEGY
• 11.5 CAREGEN
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 TYPES OFFERED
  • 11.5.3 PATENT DETAILS
  • 11.5.4 PRODUCTION CAPACITY
  • 11.5.5 SALES VOLUME
  • 11.5.6 PRICING ANALYSIS
  • 11.5.7 SWOT ANALYSIS
  • 11.5.8 KEY STRATEGY
• 11.6 BASF SE
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 TYPES OFFERED
  • 11.6.4 PATENT DETAILS
  • 11.6.5 PRODUCTION CAPACITY
  • 11.6.6 SALES VOLUME
  • 11.6.7 PRICING ANALYSIS
  • 11.6.8 SWOT ANALYSIS
  • 11.6.9 KEY STRATEGY
• 11.7 EVONIK INDUSTRIES AG
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 TYPES OFFERED
  • 11.7.4 PATENT DETAILS
  • 11.7.5 PRODUCTION CAPACITY
  • 11.7.6 SALES VOLUME
  • 11.7.7 PRICING ANALYSIS
  • 11.7.8 SWOT ANALYSIS
  • 11.7.9 KEY STRATEGY
• 11.8 GIVAUDAN ACTIVE BEAUTY
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 TYPES OFFERED
  • 11.8.4 PATENT DETAILS
  • 11.8.5 PRODUCTION CAPACITY
  • 11.8.6 SALES VOLUME
  • 11.8.7 PRICING ANALYSIS
  • 11.8.8 SWOT ANALYSIS
  • 11.8.9 KEY STRATEGY
• 11.9 ASHLAND GLOBAL HOLDINGS
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 TYPES OFFERED
  • 11.9.4 PATENT DETAILS
  • 11.9.5 PRODUCTION CAPACITY
  • 11.9.6 SALES VOLUME
  • 11.9.7 PRICING ANALYSIS
  • 11.9.8 SWOT ANALYSIS
  • 11.9.9 KEY STRATEGY
• 11.10 SYMRISE AG
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 TYPES OFFERED
  • 11.10.4 PATENT DETAILS
  • 11.10.5 PRODUCTION CAPACITY
  • 11.10.6 SALES VOLUME
  • 11.10.7 PRICING ANALYSIS
  • 11.10.8 SWOT ANALYSIS
  • 11.10.9 KEY STRATEGY
• 11.11 PROVITAL GROUP
  • 11.11.1 COMPANY OVERVIEW
  • 11.11.2 TYPES OFFERED
  • 11.11.3 PATENT DETAILS
  • 11.11.4 PRODUCTION CAPACITY
  • 11.11.5 SALES VOLUME
  • 11.11.6 PRICING ANALYSIS
  • 11.11.7 SWOT ANALYSIS
  • 11.11.8 KEY STRATEGY
• 11.12 SPEC-CHEM INDUSTRY INC
  • 11.12.1 COMPANY OVERVIEW
  • 11.12.2 TYPES OFFERED
  • 11.12.3 PATENT DETAILS
  • 11.12.4 PRODUCTION CAPACITY
  • 11.12.5 SALES VOLUME
  • 11.12.6 PRICING ANALYSIS
  • 11.12.7 SWOT ANALYSIS
  • 11.12.8 KEY STRATEGY
• 11.13 AMBIOPHARM
  • 11.13.1 COMPANY OVERVIEW
  • 11.13.2 TYPES OFFERED
  • 11.13.3 PATENT DETAILS
  • 11.13.4 PRODUCTION CAPACITY
  • 11.13.5 SALES VOLUME
  • 11.13.6 PRICING ANALYSIS
  • 11.13.7 SWOT ANALYSIS
  • 11.13.8 KEY STRATEGY
• 11.14 LIPOTEC
  • 11.14.1 COMPANY OVERVIEW
  • 11.14.2 TYPES OFFERED
  • 11.14.3 PATENT DETAILS
  • 11.14.4 PRODUCTION CAPACITY
  • 11.14.5 SALES VOLUME
  • 11.14.6 PRICING ANALYSIS
  • 11.14.7 SWOT ANALYSIS
  • 11.14.8 KEY STRATEGY
• 11.15 USV PRIVATE LIMITED
  • 11.15.1 COMPANY OVERVIEW
  • 11.15.2 TYPES OFFERED
  • 11.15.3 PATENT DETAILS
  • 11.15.4 PRODUCTION CAPACITY
  • 11.15.5 SALES VOLUME
  • 11.15.6 PRICING ANALYSIS
  • 11.15.7 SWOT ANALYSIS
  • 11.15.8 KEY STRATEGY
• 11.16 CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH (CLR)
  • 11.16.1 COMPANY OVERVIEW
  • 11.16.2 TYPES OFFERED
  • 11.16.3 PATENT DETAILS
  • 11.16.4 PRODUCTION CAPACITY
  • 11.16.5 SALES VOLUME
  • 11.16.6 PRICING ANALYSIS
  • 11.16.7 SWOT ANALYSIS
  • 11.16.8 KEY STRATEGY
• 11.17 ACTIVE PEPTIDE COMPANY
  • 11.17.1 COMPANY OVERVIEW
  • 11.17.2 TYPES OFFERED
  • 11.17.3 PATENT DETAILS
  • 11.17.4 PRODUCTION CAPACITY
  • 11.17.5 SALES VOLUME
  • 11.17.6 PRICING ANALYSIS
  • 11.17.7 SWOT ANALYSIS
  • 11.17.8 KEY STRATEGY
• 11.18 SEIWA KASEI CO., LTD
  • 11.18.1 COMPANY OVERVIEW
  • 11.18.2 TYPES OFFERED
  • 11.18.3 PATENT DETAILS
  • 11.18.4 PRODUCTION CAPACITY
  • 11.18.5 SALES VOLUME
  • 11.18.6 PRICING ANALYSIS
  • 11.18.7 SWOT ANALYSIS
  • 11.18.8 KEY STRATEGY
• 11.19 RS SYNTHESIS
  • 11.19.1 COMPANY OVERVIEW
  • 11.19.2 TYPES OFFERED
  • 11.19.3 PATENT DETAILS
  • 11.19.4 PRODUCTION CAPACITY
  • 11.19.5 SALES VOLUME
  • 11.19.6 PRICING ANALYSIS
  • 11.19.7 SWOT ANALYSIS
  • 11.19.8 KEY STRATEGY
• 11.20 BCN PEPTIDES
  • 11.20.1 COMPANY OVERVIEW
  • 11.20.2 TYPES OFFERED
  • 11.20.3 PATENT DETAILS
  • 11.20.4 PRODUCTION CAPACITY
  • 11.20.5 SALES VOLUME
  • 11.20.6 PRICING ANALYSIS
  • 11.20.7 SWOT ANALYSIS
  • 11.20.8 KEY STRATEGY